XML 28 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Note 5 - Stock-based Compensation
12 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]

NOTE
5.
STOCK-BASED COMPENSATION

Stock Option Plan
Our
2000
Stock Option Plan, as amended, provides for issuance to employees, directors, and certain service providers of incentive stock options and nonstatutory stock options. Generally, the options
may
be exercised at any time prior to expiration, subject to vesting based on terms of employment. The period ranges from immediate vesting to vesting over a
five
-year period. The options have exercisable lives ranging from
one
year to
ten
years from the date of grant, and are generally
not
eligible to vest early in the event of retirement, death, disability, or change in control. Exercise prices are
not
less than fair market value of the underlying Common Stock at the date the options are granted. Stock-based compensation expense was
$45,572
in fiscal
2021
and
$48,360
in fiscal
2020.

 
Valuation assumptions
We use the Black-Scholes standard option-pricing model to determine the fair value of stock options. The following assumptions were used to estimate the fair value of options granted:
 
   
Year
Ended
March
31
   
2021
   
2020
Risk-free interest rate
 
 0.2
0.4%
 
   
1.7
%
Expected volatility
 
 34
35%
 
   
37
%
Expected life (years)
 
 
4.6
 
     
4.6
 
Dividend yield
 
 7.0
7.4%
 
   
5.9
%
 
The determination of the fair value of the awards on the date of grant using the Black-Scholes model is affected by our stock price as well as assumptions of other variables, including projected stock option exercise behaviors, risk-free interest rate, and expected volatility of our stock price in future periods. Our estimates and assumptions affect the amounts reported in the financial statements and accompanying notes.
 
Expected life
We analyze historical exercise and termination data to estimate the expected life assumption. We believe historical data currently represents the best estimate of the expected life of a new option.

Risk-free interest rate
The risk-free rate is based on the yield of U.S. Treasury securities on the grant date for maturities similar to the expected lives of the options.

Volatility
We use historical volatility to estimate the expected volatility of our common stock.

Dividend yield
We assumed a
7.0%
to
7.4%
dividend yield for fiscal
2021
and
5.9%
for fiscal
2020
based on the dividend yield on the date the options were granted.

Tax effects of stock-based compensation
Stock-based compensation increased deferred tax assets by
$9,971
for fiscal
2021
and
$10,581
for fiscal
2020.


General stock option information
The following table summarizes information on options outstanding as of
March 
31,
2021:
 
Ranges of

Exercise
Prices
 
Number

Outstanding
   
Weighted
Average

Exercise
Price
   
Weighted
Remaining

Contractual
Life
(years)
 
$49.86
$67.69
   
22,000
    $
59.85
     
5.3
 
$76.13
$107.86
   
8,000
     
92.00
     
6.9
 
 
 
 
   
30,500
    $
68.28
     
5.7
 
 
A summary of our stock options is shown in the following table:
 
   
Option
Shares

Reserved
   
Options

Outstanding
   
Weighted Average

Option
Exercise
Price
 
At March 31, 2019
   
135,230
     
22,000
    $
70.89
 
Granted
   
(4,000
)
   
4,000
    $
67.65
 
Exercised
   
-
     
(2,000
)
  $
56.18
 
At March 31, 2020
   
131,230
     
24,000
    $
71.58
 
Granted
   
(6,500
)
   
6,500
    $
56.12
 
At March 31, 2021
   
124,730
     
30,500
    $
68.28
 
 
The remaining weighted-average exercisable life was
5.7
 years as of
March 
31,
2021
and
6.6
 years as of
March 
31,
2020.
28,000
outstanding options were exercisable as of
March 
31,
2021
and
24,000
outstanding options were exercisable as of
March 31, 2020.
The total intrinsic value of options outstanding
March 
31,
2021,
based on our closing stock price for that day, was
$230,540,
$191,140
of which was exercisable. The total fair value of option grants was
$47,140
in fiscal
2021.
There was
$1,568
of unrecognized stock-based compensation as of
March 31, 2021
related to nonvested options, which we expect to recognize in the
first
quarter of fiscal
2022.